CD8A and neoplasm: This may suggest the presence of two different protective networks: a protective “effector” TIL network (CD3–CD8) at the tumor center, as well as a protective “effector/suppressor” TIL balance (C3FR–C8FR) at the tumor margin, possibly to control relapse-initiating CSCs and EMT.